-
Organigram Receives Government Approval For 17 More Cultivation Rooms
Monday, June 24, 2019 - 10:42am | 324Read More...Organigram Holdings Inc. (NASDAQ: OGI) is more than doubling its number of cultivation rooms after receiving approval from Health Canada. The authorization will add 17 cultivation rooms to the cannabis producer's previously licensed 13, the company said Monday. Why It Matters The 17...
-
ThermoGenesis Cord Blood Processing System Wins Health Canada Approval
Tuesday, June 18, 2019 - 10:27am | 231Read More...Cesca Therapeutics (NASDAQ: KOOL) shares spiked higher after the company's subsidiary, ThermoGenesis, received Health Canada approval for its AXP II System for cord blood processing. "Health Canada's approval of the AXP II -- following its approval of the PXP System earlier this year...
-
Neptune Subsidiary Receives License Amendment Approval From Health Canada
Monday, June 17, 2019 - 11:00am | 438Read More...A subsidiary of Neptune Wellness Solutions Inc. (NASDAQ: NEPT), 9354-7537 Québec Inc., has received approval for cannabis license amendments from Health Canada. Why It Matters The key amendment to 9354-7537 Québec's license raises the company's extraction capacity....
-
Meet VBI Vaccines, The Biotech Up 100% In 2017
Tuesday, March 7, 2017 - 1:30pm | 582Read More...If you've been too distracted by the Snap Inc (NYSE: SNAP) IPO lottery ticket trade to keep your eye on small-cap biotech moves, you may not have noticed VBI Vaccines, Inc. - Ordinary Shares (NASDAQ: VBIV) shares quietly doubling in value since the start of the year. VBI Vaccines is a...
-
Orexigen Shares Up 14% After Commercialization, Distribution Deal With Valeant Canada
Tuesday, August 30, 2016 - 9:49am | 346Read More...Orexigen Therapeutics, Inc. (NASDAQ: OREX) and Valeant Canada, a subsidiary of Valeant Pharmaceuticals Intl Inc (NYSE: VRX), struck an agreement on commercialization and distributorship for Contrave. Following the news, Orexigen traded up by more than 12 percent in the pre-market trading. Orexigen...
-
Second Sight Medical Products Spikes 10% Following Health Canada Approval
Monday, January 12, 2015 - 10:51am | 200Read More...Second Sight Medical Products Inc (NASDAQ: EYES) spiked up over 10 percent Monday following an announcement that Health Canada has approved the company’s Argus II Retinal Prosthesis System to treat individuals with severe to profound outer retinal degeneration. According to the company...
